Carlos Manuel de Castro
Professor of MedicineOverview
Clinical research projects have focused on new and innovative treatments for myelodysplastic syndromes, paroxysmal nocturnal hemoglobinuria, adult leukemias, and lymphomas
Positions
Professor of Medicine in the School of Medicine
2021 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
1988 School of Medicine
Education
M.D., University of Texas, Dallas 1985
1985 University of Texas, Dallas
Resident, University of Texas, Dallas, Medicine 1985 - 1988
1988 University of Texas, Dallas
Fellow in Hematology-Oncology, Duke University, Medicine 1988 - 1991
1991 Duke University
Publications, Grants & Awards
- Grants (24)
- Academics Articles (72)
- Conference Pages (16)
Showing 1 - 5 of 24
External Quality Assurance Program Oversight Laboratory (EQAPOL)
National Institutes of Health
Novartis: Single-Arm, Open-Label, Ph2 of MBG453 added to Hypomethylating Agent for MDS
Novartis Pharmaceuticals Corporation
CLNP023C12303
Novartis Pharmaceuticals Corporation
Apellis AP2-307--Extension PNH
Apellis Pharmaceuticals, Inc
EQAPOL - Years 2017 to 2024 - BASE
National Institutes of Health
DCI Centers, Cancer Types & Labs
Offices & Contact
Box 3961
Durham, NC
27710
Box 3961 Med Ctr
Durham, NC
27710